Enjoy complimentary customisation on priority with our Enterprise License!
The in situ hybridization (ISH) market share is expected to increase by USD 475.05 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 7%.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by technology (FISH and CISH), end-user (molecular diagnostic laboratories, pharmaceutical and biotechnological companies, and others), and geography (North America, Europe, Asia, and ROW).
The in situ hybridization (ISH) market report also offers information on several market vendors, including Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. among others.
Abbott Laboratories - The company offers Vysis CEP 12 SpectrumOrange DNA Probe Kit among others. Under the established pharmaceuticals products segment, the company manufactures medicines for established and emerging markets. Under the nutritional products segment, the company offers a line of pediatric and adult nutritional products.
Get the In Situ Hybridization (ISH) Market Size Forecast by Downloading the Report Sample
Technavio categorizes the global in situ hybridization market as a part of the global life science tools and services market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the in situ hybridization (ISH) market during the forecast period.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key In Situ Hybridization (ISH) Market Driver
Key In Situ Hybridization (ISH) Market Challenge
This in situ hybridization (ISH) market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our In-house experts produce extensive information on the value chain and parent market of the in situ hybridization (ISH) market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions by Requesting a PDF Sample now!
43% of the market’s growth will originate from North America during the forecast period. The US is the key market for in situ hybridizations (ISH) in North America. Market growth in this region will be faster than the growth of the market in the European regions.
The growing incidence of diseases, such as cancer, which require molecular diagnosis, is also on the rise in these countries and thus contributes to the demand for ISH techniques. The US has also been at the centre of R&D of FISH probe technologies due to the increasing cases of cancer in the region. This will facilitate the in situ hybridization (ISH) market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The rise in the incidence of COVID-19 in North America compelled governments to introduce emergency legislation, which included restrictions on several operational activities across industries. This led to the shutting down of several manufacturing units, including those of ISH products, in 2020. In addition, disruptions in the supply of raw materials required for manufacturing ISH products and the limited availability of workforce lowered the production volume of ISH products in North America in the first few months of 2020. However, the rising incidence of COVID-19 increased the demand for ISH products for diagnostic purposes, which, in turn, increased the demand for high production volume of ISH products from mid-2020. This, in turn, resulted in a moderate growth of the in situ hybridization market in North America in 2020.
To gain insights on the market contribution of various segments Request a PDF Sample
The in situ hybridization (ISH) market share growth by the FISH segment will be significant during the forecast period. FISH can detect cancer mutations, cancer-causing genes, as well as rare genetic disorders such as Angelman syndrome, Prader-Willi syndrome, acute lymphoblastic leukaemia, chronic myelogenous leukaemia, cri-du-chat disease, and Down syndrome. The prevalence of these rare diseases along with the high incidence and prevalence of cancer across the globe contributes to the higher demand for FISH in the market. Additionally, with the rising number of chromosomal defects among fetuses, an increasing number of expectant mothers are undergoing screening procedures to detect genetic abnormalities at an early stage.
This report provides an accurate prediction of the contribution of all the segments to the growth of the in situ hybridization (ISH) market size and actionable market insights on the post-COVID-19 impact on each segment.
In Situ Hybridization (ISH) Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7% |
Market growth 2021-2025 |
$ 475.05 million |
Market structure |
Fragmented |
YoY growth (%) |
6.80 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 43% |
Key countries |
US, Germany, Japan, France, and Australia |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.